This statistic was assembled from several editions of Johnson & Johnson's annual financial report.
* Lower sales due to the spin-off of Johnson & Johnson's consumer health business (now under the new name Kenvue) during 2023.
In 2025, Johnson & Johnson generated approximately ** billion U.S. dollars in sales. Johnson & Johnson is a multinational company, specializing in pharmaceuticals, medical devices, and consumer goods. The company is headquartered in New Brunswick, New Jersey.
Johnson & Johnson’s global position
Johnson & Johnson has been ranked among the top pharmaceutical companies globally recently and in multiple categories. As of 2025, it was the leading pharmaceutical company worldwide in terms of total revenue generated. Furthermore, Johnson and Johnson was also the leading pharmaceutical company globally by prescription sales revenue in 2024, as well as being the second-ranked company worldwide in terms of its research and development spending.
Johnson & Johnson’s research and development
Johnson and Johnson’s research and development expenditure has been steadily and gradually increasing in the past five years. In 2024, the company spent over ** billion U.S. dollars on research and development, accounting for some **percent of total sales that year.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Johnson & Johnson, & U.S. Securities and Exchange Commission. (February 11, 2026). Revenue of Johnson & Johnson from 2005 to 2025 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 28, 2026, from /statistics/266403/total-revenue-of-johnson-und-johnson-since-2004/
Johnson & Johnson, und U.S. Securities and Exchange Commission. "Revenue of Johnson & Johnson from 2005 to 2025 (in million U.S. dollars)." Chart. February 11, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 28, 2026. /statistics/266403/total-revenue-of-johnson-und-johnson-since-2004/
Johnson & Johnson, U.S. Securities and Exchange Commission. (2026). Revenue of Johnson & Johnson from 2005 to 2025 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 28, 2026. /statistics/266403/total-revenue-of-johnson-und-johnson-since-2004/
Johnson & Johnson, and U.S. Securities and Exchange Commission. "Revenue of Johnson & Johnson from 2005 to 2025 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 11 Feb 2026, /statistics/266403/total-revenue-of-johnson-und-johnson-since-2004/
Johnson & Johnson & U.S. Securities and Exchange Commission, Revenue of Johnson & Johnson from 2005 to 2025 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/266403/total-revenue-of-johnson-und-johnson-since-2004/ (last visited July 28, 2026)
Revenue of Johnson & Johnson from 2005 to 2025 (in million U.S. dollars) [Graph], Johnson & Johnson, & U.S. Securities and Exchange Commission, February 11, 2026. [Online]. Available: /statistics/266403/total-revenue-of-johnson-und-johnson-since-2004/
